1. Current trends in the promising immune checkpoint inhibition and radiotherapy combination for locally advanced and metastatic urothelial carcinoma

   • Takeshi Sano
   • Ryoichi Saito
   • Takashi Kobayashi

   Review Article 24 October 2023 Pages: 1573 - 1584

   

2. Clinical and imaging features of interstitial lung disease in cancer patients treated with trastuzumab deruxtecan

   • Tomohisa Baba
   • Masahiko Kusumoto
   • Kazuyoshi Kuwano

   Original Article Open access 03 October 2023 Pages: 1585 - 1596

   

3. Clinicopathological characteristics of four major histological types of high-grade parotid carcinoma

   • Ryo Kawata
   • Ichita Kinoshita
   • Takeshi Tochizawa

   Original Article 13 October 2023 Pages: 1597 - 1606

   

4. Clinical course of longer than five years after definitive radiotherapy for nasopharyngeal carcinoma

   • Hiroshi Doi
   • Aritoshi Ri
   • Yasumasa Nishimura

   Original Article 05 October 2023 Pages: 1607 - 1615

   

5. The predictive value of advanced lung cancer inflammation index for short-term outcomes and prognosis of colorectal cancer patients who underwent radical surgery

   • Bin Zhang
   • Zi-Wei Li
   • Dong Peng

   Original Article 12 September 2023 Pages: 1616 - 1624

   

6. Oral frailty is a risk factor for body weight loss after gastrectomy: a single-center, retrospective study

   • Ryugo Teranishi
   • Kazuyoshi Yamamoto
   • Yuichiro Doki

   Original Article 25 October 2023 Pages: 1625 - 1632

   

7. Risk of metachronous colorectal cancer after colectomy for first colon cancer in Lynch syndrome: multicenter retrospective study in Japan

   • Kenichi Chikatani
   • Hideyuki Ishida
   • Yoichi Ajioka

   Original Article 26 September 2023 Pages: 1633 - 1640

   

8. Usefulness of genotyping APC gene for individualizing management of patients with familial adenomatous polyposis

   • Yoshiko Mori
   • Hideyuki Ishida
   • Yoichi Ajioka

   Original Article 18 October 2023 Pages: 1641 - 1650

   

9. Association between immune-related adverse events and survival in patients with renal cell carcinoma treated with nivolumab plus ipilimumab: immortal time bias-corrected analysis

   • Satoshi Washino
   • Suguru Shirotake
   • Tomoaki Miyagawa

   Original Article 02 September 2023 Pages: 1651 - 1658

   

10. Can contralateral lymph-node metastases be ruled out in prostate cancer patients with only unilaterally positive prostate biopsy?

    • Bianca Michalik
    • Svenja Engels
    • Alexander Winter

    Original Article Open access 07 September 2023 Pages: 1659 - 1666

    

11. Intentions for catch-up HPV vaccination in Japan: an internet survey

    • Satoshi Nakagawa
    • Asami Yagi
    • Tadashi Kimura

    Original Article Open access 30 September 2023 Pages: 1667 - 1679

12. Mean platelet volume as a potential biomarker for survival outcomes in ovarian clear cell carcinoma

    • Nobuhisa Yoshikawa
    • Tetsuya Matsukawa
    • Hiroaki Kajiyama

    Original Article 07 October 2023 Pages: 1680 - 1689

    

13. Prognostic factors in cutaneous apocrine carcinoma: a single-institution retrospective study of 32 patients

    • Seiji Tsuruta
    • Dai Ogata
    • Naoya Yamazaki

    Original Article 06 October 2023 Pages: 1690 - 1696

    

14. Correction to: Comparison of outcomes in high‑risk prostate cancer patients treated with low‑/high‑dose‑rate brachytherapy plus external beam radiotherapy

    • Yu Imai
    • Fumihiko Urabe
    • Takahiro Kimura

    Correction 09 October 2023 Pages: 1697 - 1697

15. List of reviewers 2022–2023

    Acknowledgments 10 November 2023 Pages: 1698 - 1702